Concord Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22

Sales

451.05

525.98

457.17

339.90

Operating profit

151.93

217.96

191.34

102.55

Interest

0.12

0.34

1.59

2.15

Gross profit

178.92

237.95

204.53

114.26

EPS (Rs)

10.08

15.00

12.71

6.27

Other income

27.11

20.33

14.78

13.86

Stock adjustment

-49.58

-31.95

-10.28

-17.93

Raw material

117.21

123.09

81.48

80.37

Power and fuel

-

-

-

-

Employee expenses

81.08

65.33

58.42

54.05

Excise

-

-

-

-

Admin and selling expenses

-

-

-

-

Research and development expenses

-

-

-

-

Expenses capitalised

-

-

-

-

Other expenses

150.40

151.56

136.22

120.87

Provisions made

-

-

-

-

Depreciation

36.17

26.49

26.34

26.08

Taxation

37.30

54.52

45.23

22.64

Net profit / loss

105.46

156.94

132.96

65.55

Extra ordinary item

-

-

-

-

Prior year adjustments

-

-

-

-

Equity capital

10.46

10.46

10.46

10.46

Equity dividend rate

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

OPM (%)

33.68

41.44

41.85

30.17

GPM (%)

37.42

43.56

43.34

32.30

NPM (%)

22.06

28.73

28.17

18.53